what are the risks of glp 1 GLP-1 Drugs Use, Risks, and Regulation Know more :https://pib.gov.in/PressReleasePage.aspx?PRID=2247459 Benefit-Risk Assessment of GLP-1 Receptor

Baseline gut microbiota is considered a primary factor influencing individual responses to dietary interventions ( 6.4 Novel perspectives in pharmacotherapy 6.4.1 Effects of conventional medications on microbiota Antidepressant medications have antimicrobial properties that can directly affect gut microbiota ( Akkermansia muciniphila and Escherichia coli , respectively ( Faecalibacterium and Parasutterella in antidepressant-treated patients with MDD were consistently depleted, along with Bifidobacterium enrichment ( 6.4.2 Novel microbiota-targeted therapeutics The development of novel therapeutics based on gut microbial mechanisms is emerging

Furthermore, GSH also has skin-whitening properties as it inhibits melanin production

While there are various peptides that can be used for sleep improvement, some have demonstrated particular efficacy in this regard

[DOI] [PMC free article] [PubMed] [Google Scholar] 6.Afkarian M., Sachs M.C., Kestenbaum B., et al